Back to Trades
Sell4
IONIS PHARMACEUTICALS INC
IONS
Total Value
$3.0M
Net $1.6M sold
Sales
$1.6M
3 transactions
Company Information
- Company Name
- IONIS PHARMACEUTICALS INC
- Ticker Symbol
- IONS
- CIK
- 0000874015
Insider Information
- Role
- EVP, Chief Human Resources Ofc
- Location
- CARLSBAD, CA
Officer
Filing Details
- Filing Date
- Mar 5, 2026
- Transaction Date
- Mar 3, 2026
- Accession Number
- 0000874015-26-000135
- Form Type
- 4
- Net Trading Amount
- -$1.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | 3,510 | $37.58 | Exercise | $131.9K |
| Mar 3, 2026 | Common Stock | 3,760 | $40.85 | Exercise | $153.6K |
| Mar 3, 2026 | Common Stock | 5,500 | $34.69 | Exercise | $190.8K |
| Mar 3, 2026 | Common Stock | 6,951 | $32.60 | Exercise | $226.6K |
| Mar 3, 2026 | Common Stock | 385 | $52.87 | Exercise | $20.4K |
| Mar 3, 2026 | Common Stock | 14,321 | $79.12 | Sale | $1.1M |
| Mar 3, 2026 | Common Stock | 5,030 | $80.00 | Sale | $402.4K |
| Mar 3, 2026 | Common Stock | 755 | $80.84 | Sale | $61.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Derivative | 6,951 | $32.60 | Exercise | $226.6K |
| Mar 3, 2026 | Derivative | 5,500 | $34.69 | Exercise | $190.8K |
| Mar 3, 2026 | Derivative | 3,510 | $37.58 | Exercise | $131.9K |
| Mar 3, 2026 | Derivative | 3,760 | $40.85 | Exercise | $153.6K |
| Mar 3, 2026 | Derivative | 385 | $52.87 | Exercise | $20.4K |
Footnotes
- (F1)Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 24, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.61 to $79.60 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.68 to $80.675 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.76 to $81.01 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.